A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Bacterial vaginosis increases the risk of spontaneous preterm delivery at less than 34 weeks of gestation. OBJECTIVE: The purpose of this study was to evaluate the efficacy of the early administration of selected lactobacilli strains (probiotics) to pregnant women with asymptomatic bacterial vaginosis/intermediate-degree infections to prevent spontaneous premature delivery and associated neonatal morbidity. METHODS/DESIGN: Asymptomatic pregnant women at less than 20 weeks of gestation, with no indication of elective preterm delivery, with a vaginal pH ≥ 4.5 and Nugent score > 3 were randomly assigned to the placebo or intervention group (oral administration of selected lactobacilli up to the 24th to 26th week of gestation). The randomisation was stratified for the history of premature delivery (HPD) and blocked. The allocation was concealed, and the participating health professionals and patients were blinded. The primary outcome was preterm delivery (<34 to <32 weeks), and the secondary outcomes were associated neonatal complications. RESULTS: In total, 4,204 pregnant women were screened; 320 and 324 individuals were respectively randomly assigned to the placebo and intervention groups, and 62% finished the trial. None of the randomised patients were lost to follow-up. For the non-HPD stratum, the intent-to-treat relative risks of spontaneous premature birth at < 34 and < 37 weeks' gestation were 0.33 (0.03, 3.16) and 0.49 (0.17, 1.44), respectively, and they were non-significant (ns) with p = 0.31 and 0.14. The corresponding actual treatment figures were zero and 0.32 (0.09, 1.19), which were ns with p = 0.12 and 0.06. The intent-to-treat relative risk of spontaneous premature birth at < 37 weeks of gestation for the trial as a whole, including HPD and non-HPD participants, was 0.69 (0.26, 1.78), p = 0.30 (ns). The neonatal complications under evaluation occurred in only one infant (< 34 weeks; placebo group) who presented with respiratory distress syndrome and suspected early neonatal sepsis. The recorded adverse events were minor and relatively non-specific. CONCLUSIONS: The efficacy of the tested probiotics to prevent preterm delivery among women without a history of preterm delivery was not determined because the study sample was insufficient to estimate statistically significant intent-to-treat effects; additional studies are needed to evaluate this intervention among these women. TRIAL REGISTRATION: Trial registration at NIH register: NCT00303082. Sources of funding: the Brazilian Health Ministry and the State of Rio de Janeiro Research Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · Trials · doi:10.1186/1745-6215-11-32 · Cited by 1,871
The fetal inflammatory response syndrome
Gomez, R., Romero, R., Ghezzi, F., Yoon, B. H., Mazor, M., & Berry, S. M. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70272-8 · Cited by 1,111
Yoon, B. H., Romero, R., Yang, S. H., Jun, J. K., Kim, I.-O., Choi, J.-H., & Syn, H. C. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70585-9 · Cited by 584 · cited 1×
“Prematurity resulting from intrauterine infections increases the probability of complications, including early sepsis, bronchopulmonary dysplasia, periventricular leukomalacia, and necrotising enterocolitis [10-13], which may cause long-term neurological disabilities and death.”
BackgroundA fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition
Romero, R., Gomez, R., Ghezzi, F., Yoon, B. H., Mazor, M., Edwin, S. S., & Berry, S. M. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70271-6 · Cited by 546 · cited 2×
“Furthermore, the fact that such HPD cases are generally considered especially difficult to understand and solve [7,42] prompted the authors to analyse the data from the non-HPD group separately.”
BackgroundReid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R., & Bruce, A. W. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(02)00465-0 · Cited by 514
Oral probiotics can resolve urogenital infections
Reid, G., Bruce, A. W., Fraser, N., Heinemann, C., Owen, J., & Henning, B. (2001) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(00)00233-9 · Cited by 464
The preterm prediction study: significance of vaginal infections
Meis, P. J., Goldenberg, R. L., Mercer, B., Moawad, A., Das, A., McNellis, D., Johnson, F., Iams, J. D., Thom, E., & Andrews, W. W. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)91360-2 · Cited by 410 · cited 1×
“Three out of five women who spontaneously delivered prior to the 34 week of gestation exhibited initial Nugent scores of 9 or 10; these scores were present in less than 15% of the total number randomised women, which is consistent with the hypothesis that BV is a risk factor for premature birth in the study population…”
ResultA systemic fetal inflammatory response and the development of bronchopulmonary dysplasia
Yoon, B. H., Romero, R., Kim, K. S., Park, J. S., Ki, S. H., Kim, B. I., & Jun, J. K. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70299-1 · Cited by 368
Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora
Reid, G., Beuerman, D., Heinemann, C., & Bruce, A. W. (2001) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2001.tb00531.x · Cited by 328 · cited 1×
“Four small trials have tested the efficacy and safety of selected probiotics (generally, Lactobacillus rhamnosus GR-1 associated with Lactobacillus fermentum TC-14) for curing urogenital infections, including BV, in asymptomatic non-pregnant women [26-30].”
Background
Research works printed but not linked: 41
- Agency for Healthcare Research and Quality: Management of preterm labor. Evidence report/technology assessment n. 18, AHRQ public n. 01-E021. 2000
- Leal MC, Gama SGN, Campos MR: Fatores associados à morbi-mortalidade perinatal em uma amostra de maternidades públicas e privadas do município do Rio de Janeiro, 1999-2001. Cadernos de Saúde Pública. 2004, 20 (Supl 1): S20-S33. · DOI
- Campos MR, Leal MC, Souza PR, Cunha CB: Consistência entre fontes de dados e confiabilidade inter-observador do estudo da morbi-mortalidade e atenção peri e neonatal no município do Rio de Janeiro. Cadernos de Saúde Pública. 2004, 20 (Supl 1): S34-S43. · DOI
- Berkowitz GS, Prince CB, Lapinski RH: Risk factors for preterm birth subtypes. Epidemiology. 1998, 9 (3): 279-285. 10.1097/00001648-199805000-00011. · DOI · Paper page
- Goldenberg RL, Andrews WW, Hauth JC: Choriodecidual infection and preterm birth. Nutrition Reviews. 2002, 60 (5): S19-S25. 10.1301/00296640260130696. · DOI
- Romero R, Espinoza J, Chaiworapongsa T, Kalache K: Infections and prematurity and the role of preventive strategies. Semin Neonatol. 2002, 7: 259-274. · doi:10.1016/s1084-2756(02)90121-1 · Paper page
- Goldenberg RL, Iams JD, Mercer BM, Meis P, Moawad A, Das A, Copper R, Johnson F, for the national Institute of Child Health and Human Development Network: What we have learned about the predictors of preterm birth. Seminars in Perinatology. 2003, 27 (3): 185-93. 10.1016/S0146-0005(03)00017-X. · DOI
- Mercer BM, Goldenberg RL, Das A: The preterm prediction study: A clinical risk assessment system. Am J Obstet Gynecol. 1996, 174 (6): 1885-1895. 10.1016/S0002-9378(96)70225-9. · DOI · Paper page
- Klebanoff MA, Hauth JC, MacPherson CA, Carey JC, Heine RP, Wapner RJ, Iams JD, Moawad A, Miodovnik M, Sibai BM, van Dorsten JP, Dombrowski MP, for the National Institute for Child Health and Development Maternal Fetal Medicine Units Network: Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. American Journal of Obstetrics and Gynecology. 2004, 190 (2): 363-70. 10.1016/j.ajog.2003.08.020. · DOI
- Yoon BH, Romero R, Park JS, Kim M, Oh SY, Jun JK: The relationships among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000, 183 (5): 1124-9. 10.1067/mob.2000.109035. · DOI · Paper page
- Cauci S: Vaginal Immunity in Bacterial Vaginosis. Current Infectious Disease Reports. 2004, 6 (6): 450-6. 10.1007/s11908-004-0064-8. · DOI
- McGregor JÁ, French JI, Richter R: Cervicovaginal microflora and pregnancy outcome: results of double-blind, placebo-controlled trial of erythromycin. Am J Obstet Gynecol. 1990, 163 (5 Pt 1): 1580-91. · DOI
- Hauth JC, Goldenberg RL, Andrews WW: Reduced Incidence of Preterm Delivery With Metronidazole and Erythromycin in Women with Bacterial Vaginosis. N Engl J Med. 1995, 333 (26): 1732-6. 10.1056/NEJM199512283332603. · DOI · Paper page
- Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, Wapner R, Varner M, Trout W, Moawad A, Sibai BM, Miodovnik M, Dombrowski M, O'Sullivan MJ, van Dorsten JP, Langer O, Roberts J: Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal and Fetal Medicine Units. N Engl J Med. 2000, 343 (8): 534-40. · DOI · Paper page
- Andrews WW, Sibai BM, Thom EA, Dudley D, Ernest JM, McNellis D, Leveno KJ, Wapmer R, Moawad A, O'Sullivan MJ, Caritis SN, Iams JD, Langer O, Miodovnik M, Dombrowski M, for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network: Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol. 2003, 101 (5): 847-55. 10.1016/S0029-7844(03)00172-8. · DOI · Paper page
- Simhan HN, Caritis SN, Krohn MA, Tejada BM, Landers DV, Hillier SL: Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol. 2003, 189 (2): 560-7. 10.1067/S0002-9378(03)00518-0. · DOI
- Romero R, Chaiworapongsa T, Kuivaniemi H, Tromp G: Bacterial Vaginosis. The inflammatory response and the preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol. 2004, 190 (6): 1509-19. 10.1016/j.ajog.2004.01.002. · DOI · Paper page
- Klein LL, Gibbs R: Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol. 2004, 190: 1493-502. 10.1016/j.ajog.2004.03.014. · DOI
- Isolauri E, Salminen S, Ouwehand AC: Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol. 2004, 18 (2): 299-313. 10.1016/j.bpg.2003.10.006. · DOI · Paper page
- Vrese M, Schrezenmeir J: Probiotics and non-intestinal infectious conditions. Br J Nutr. 2002, 88 (Suppl 1): S59-S66. · DOI · Paper page
- Reid G, Devillard E: Probiotics for mother and child. J Clin Gastroenterol. 2004, 38 (Suppl 2): S94-S101. · DOI
- Reid G, Bocking A: The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol. 2003, 189 (4): 1202-8. 10.1067/S0002-9378(03)00495-2. · DOI · Paper page
- Reid G, Bruce AW: Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis. 2001, 183 (Suppl 1): S77-80. · DOI · Paper page
- Shalev E: Ingestion of probiotics: Optional treatment of bacterial vaginosis in pregnancy. IMAJ. 2002, 4: 357-60.
- Krauss-Silva : Reproductive Health. 2010, 7: 14-10.1186/1742-4755-7-14. http://www.reproductive-health-journal.com/content/7/1/14 · DOI
- Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiology. 1991, 29 (2): 297-301. · DOI · Paper page
- Vermont Oxford Network. Database Manual of Operations. >Release 5.0.Burlington, VT. 2000
- Moher D, Hopewell S, Schulz KF, Montori V: CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomized trials. BMJ. 2010, 340-
- Hauth JC, Macpherson C, Carey JC, Klebanoff MA, Hillier SL, Ernest JM, Leveno KJ, Wapner R, Varner M, Trout W, Moawad A, Sibai BM, for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network: Early pregnancy threshold vagina pH and gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol. 2003, 188 (3): 831-5. 10.1067/mob.2003.184. · DOI
- Simhan HN, Caritis NS, Krohn MA, Hillier SL: Elevated Vaginal pH And Neutrophils Are Associated Strongly with Early Spontaneous Preterm Birth. Am J Obstet Gynecol. 2003, 189 (4): 1150-4. 10.1067/S0002-9378(03)00582-9. · DOI
- Monga M, Blanco J: Intrauterine Infection and Preterm Labor. Inf Dis Obstet Gynecol. 1995, 3: 37-44. 10.1155/S1064744995000287. · DOI
- Mercer BM: Preterm Premature Rupture of Membranes. Obstet Gynecol. 2003, 101: 178-193. 10.1016/S0029-7844(02)02366-9. · DOI · Paper page
- Goldenberg R, Culhane JF, Iams J, Romero R: Epidemiology and causes of preterm birth. The Lancet. 2008, 371: 75-84. 10.1016/S0140-6736(08)60074-4. · DOI · Paper page
- Cloherty JP, Eichenwald EC, Stark AR: Manual of Neonatal Care. 2004, Lippincott Williams & Wilkins; Fifth edition, Philadelphia
- Pahlson C, Larsson PG: The ecologically wrong vaginal lactobacilli. Medical Hypotheses. 1991, 36: 126-130. 10.1016/0306-9877(91)90253-U. · DOI
- Famularo G, Pieluigi M, Coccia R, Mastroiacovo P, De Simone C: Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med Hypotheses. 2001, 56 (4): 421-30. 10.1054/mehy.2000.1195. · DOI
- McLean NW, Rosenstein IJ: Characterization and selection of a Lactobacillus species to recolonize the vagina of women with recurrent bacterial vaginosis. J Med Microbiol. 2000, 49: 543-52. · DOI · Paper page
- Iams JD, Goldenberg RL, Mercer BM, Moawad A, Das AF, Caritis SN, Miodovnik M, Menard MK, Thurnau GR, Dombrowski M, Roberts J, for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network: The Preterm Prediction Study: Can low-risk women destined for spontaneous preterm birth be identified?. Am J Obstet Gynecol. 2001, 184 (4): 652-655. 10.1067/mob.2001.111248. · DOI · Paper page
- Genc MR, Witkin SS, Delaney ML, Paraskevas LR, Tuomala RE, Norwitz ER, Onderdonk AB: A disproportionate increase in IL-1B over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstetrics Gynecology. 2004, 190 (5): 1191-1197.
- Kalinka J, Sobala W, Wasiela M, Brzezinska-Błaszczyk E: Decreased proinflammatory cytokines in cervicovaginal fluid, as measured in midgestation, are associated with preterm delivery. AJRI. 2005, 54: 70-76.
- Pochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A: Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol. 2002, 110 (4): 617-23. 10.1067/mai.2002.128528. · DOI · Paper page
Cited by
Microbial ecology and host-microbiota interactions during early life stages
Collado, M. C., Cernada, M., Baüerl, C., Vento, M., & Pérez-Martínez, G. (2012) · Gut Microbes · doi:10.4161/gmic.21215 · Cited by 256
Risk assessment and management to prevent preterm birth
Koullali, B., Oudijk, M. A., Nijman, T. A. J., Mol, B. W. J., & Pajkrt, E. (2016) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2016.01.005 · Cited by 186
Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis
Jarde, A., Lewis-Mikhael, A.-M., Moayyedi, P., Stearns, J. C., Collins, S. M., Beyene, J., & McDonald, S. D. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1629-5 · Cited by 161
López-Moreno, A., & Aguilera, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071461 · Cited by 97
Sheyholislami, H., & Connor, K. L. (2021) · Nutrients · doi:10.3390/nu13072382 · Cited by 75
Metadata
- Authors
- Krauss-Silva, L., Moreira, M. E. L., Alves, M. B., Braga, A., Camacho, K. G., Batista, M. R. R., Almada-Horta, A., Rebello, M. R., & Guerra, F.
- Venue
- Trials
- Published
- 2011-11-08
- Volume
- 12
- Issue
- 1
- Pages
- 239-239
- ISSN
- 1745-6215 (ISSN-L)
- OpenAlex
- W2158765817
- Cited by
- 88
- References
- 10
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/2.0 (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results. https://app.cochat.ai/papers/10.1186/1745-6215-12-239
- The paper
- Krauss-Silva, L., Moreira, M. E. L., Alves, M. B., Braga, A., Camacho, K. G., Batista, M. R. R., Almada-Horta, A., Rebello, M. R., & Guerra, F. (2011). A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results. Trials. https://doi.org/10.1186/1745-6215-12-239
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.